Skip to content

BIOLASE, INC

Delisted

CIK 811240fmd_1SZ31K0WY5F4B3M97181VGMGKGManufacturing · Dental Equipment & SuppliesTemplate: Standard

Coverage: Jan 01, 2009 to Sep 30, 2024, 59 periods

Latest annual · FY2023

Millions
Total revenues
49
Gross profit
17
Operating income
(18)
Net income
(21)
Free cash flow
(15)

Latest quarter · Q3 FY2024

Millions
Total revenues
11
Gross profit
4
Operating income
(1)
Net income
(1)
Free cash flow
(5)
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2020 to FY2023
+29.2%
Revenue, 5 yearsFY2018 to FY2023
+1.3%
Net income, 5 yearsFY2018 to FY2023
n/m

BIOLASE, INC financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2023FY2022ChangeSource
Revenue$49.2 million$48.5 million+1.4%10-K 2024-03-21 · proof
Gross profit$16.7 million$15.9 million+5.1%10-K 2024-03-21 · proof
Operating income-$17.9 million-$25.3 million10-K 2024-03-21 · proof
Net income-$20.6 million-$28.6 million10-K 2024-03-21 · proof
Cash from operating activities-$14.1 million-$26.8 million10-K 2024-03-21 · proof
Free cash flow-$15.4 million-$30.5 million10-K 2024-03-21 · proof
Total assets$35.1 million$38.2 million-8.1%10-K 2024-03-21 · proof
Total liabilities$33.1 million$33.3 million-0.5%10-K 2024-03-21 · proof
Cash and cash equivalents$6.6 million$4.2 million+57%10-K 2024-03-21 · proof
Total debt$14 million$13.8 million+1.9%10-K 2024-03-21 · proof
What was BIOLASE, INC's revenue in fiscal 2023?
BIOLASE, INC reported revenue of $49.2 million for fiscal 2023 (the year ended Dec 31, 2023), against $48.5 million the year before (+1.4%). Source: the 10-K filed with the SEC on Mar 21, 2024. SEC
What was BIOLASE, INC's gross profit in fiscal 2023?
BIOLASE, INC reported gross profit of $16.7 million for fiscal 2023 (the year ended Dec 31, 2023), against $15.9 million the year before (+5.1%). Source: the 10-K filed with the SEC on Mar 21, 2024. SEC
What was BIOLASE, INC's operating income in fiscal 2023?
BIOLASE, INC reported operating income of -$17.9 million for fiscal 2023 (the year ended Dec 31, 2023), against -$25.3 million the year before. Source: the 10-K filed with the SEC on Mar 21, 2024. SEC
What was BIOLASE, INC's net income in fiscal 2023?
BIOLASE, INC reported net income of -$20.6 million for fiscal 2023 (the year ended Dec 31, 2023), against -$28.6 million the year before. Source: the 10-K filed with the SEC on Mar 21, 2024. SEC
What was BIOLASE, INC's cash from operating activities in fiscal 2023?
BIOLASE, INC reported cash from operating activities of -$14.1 million for fiscal 2023 (the year ended Dec 31, 2023), against -$26.8 million the year before. Source: the 10-K filed with the SEC on Mar 21, 2024. SEC
What was BIOLASE, INC's free cash flow in fiscal 2023?
BIOLASE, INC reported free cash flow of -$15.4 million for fiscal 2023 (the year ended Dec 31, 2023), against -$30.5 million the year before. Source: the 10-K filed with the SEC on Mar 21, 2024. SEC
What are BIOLASE, INC's total assets?
As of Dec 31, 2023, BIOLASE, INC reported total assets of $35.1 million, against $38.2 million a year earlier (-8.1%). Source: the 10-K filed with the SEC on Mar 21, 2024. SEC
What are BIOLASE, INC's total liabilities?
As of Dec 31, 2023, BIOLASE, INC reported total liabilities of $33.1 million, against $33.3 million a year earlier (-0.5%). Source: the 10-K filed with the SEC on Mar 21, 2024. SEC
What are BIOLASE, INC's cash and cash equivalents?
As of Dec 31, 2023, BIOLASE, INC reported cash and cash equivalents of $6.6 million, against $4.2 million a year earlier (+57%). Source: the 10-K filed with the SEC on Mar 21, 2024. SEC
What is BIOLASE, INC's total debt?
As of Dec 31, 2023, BIOLASE, INC reported total debt of $14 million, against $13.8 million a year earlier (+1.9%). Source: the 10-K filed with the SEC on Mar 21, 2024. SEC

Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:811240&period_type=annual&limit=5"

Information only, not investment advice.